Cargando…

Kinetics of gene expression and bone remodelling in the clinical phase of collagen-induced arthritis

INTRODUCTION: Pathological bone changes differ considerably between inflammatory arthritic diseases and most studies have focused on bone erosion. Collagen-induced arthritis (CIA) is a model for rheumatoid arthritis, which, in addition to bone erosion, demonstrates bone formation at the time of clin...

Descripción completa

Detalles Bibliográficos
Autores principales: Denninger, Katja CM, Litman, Thomas, Marstrand, Troels, Moller, Kristian, Svensson, Lars, Labuda, Tord, Andersson, Åsa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4391727/
https://www.ncbi.nlm.nih.gov/pubmed/25889670
http://dx.doi.org/10.1186/s13075-015-0531-7
_version_ 1782365867012521984
author Denninger, Katja CM
Litman, Thomas
Marstrand, Troels
Moller, Kristian
Svensson, Lars
Labuda, Tord
Andersson, Åsa
author_facet Denninger, Katja CM
Litman, Thomas
Marstrand, Troels
Moller, Kristian
Svensson, Lars
Labuda, Tord
Andersson, Åsa
author_sort Denninger, Katja CM
collection PubMed
description INTRODUCTION: Pathological bone changes differ considerably between inflammatory arthritic diseases and most studies have focused on bone erosion. Collagen-induced arthritis (CIA) is a model for rheumatoid arthritis, which, in addition to bone erosion, demonstrates bone formation at the time of clinical manifestations. The objective of this study was to use this model to characterise the histological and molecular changes in bone remodelling, and relate these to the clinical disease development. METHODS: A histological and gene expression profiling time-course study on bone remodelling in CIA was linked to onset of clinical symptoms. Global gene expression was studied with a gene chip array system. RESULTS: The main histopathological changes in bone structure and inflammation occurred during the first two weeks following the onset of clinical symptoms in the joint. Hereafter, the inflammation declined and remodelling of formed bone dominated. Global gene expression profiling showed simultaneous upregulation of genes related to bone changes and inflammation in week 0 to 2 after onset of clinical disease. Furthermore, we observed time-dependent expression of genes involved in early and late osteoblast differentiation and function, which mirrored the histopathological bone changes. The differentially expressed genes belong to the bone morphogenetic pathway (BMP) and, in addition, include the osteoblast markers integrin-binding sialoprotein (Ibsp), bone gamma-carboxyglutamate protein (Bglap1), and secreted phosphoprotein 1 (Spp1). Pregnancy-associated protein A (Pappa) and periostin (Postn), differentially expressed in the early disease phase, are proposed to participate in bone formation, and we suggest that they play a role in early bone formation in the CIA model. Comparison to human genome-wide association studies (GWAS) revealed differential expression of several genes associated with human arthritis. CONCLUSIONS: In the CIA model, bone formation in the joint starts shortly after onset of clinical symptoms, which results in bony fusion within one to two weeks. This makes it a candidate model for investigating the relationship between inflammation and bone formation in inflammatory arthritis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13075-015-0531-7) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4391727
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-43917272015-04-10 Kinetics of gene expression and bone remodelling in the clinical phase of collagen-induced arthritis Denninger, Katja CM Litman, Thomas Marstrand, Troels Moller, Kristian Svensson, Lars Labuda, Tord Andersson, Åsa Arthritis Res Ther Research Article INTRODUCTION: Pathological bone changes differ considerably between inflammatory arthritic diseases and most studies have focused on bone erosion. Collagen-induced arthritis (CIA) is a model for rheumatoid arthritis, which, in addition to bone erosion, demonstrates bone formation at the time of clinical manifestations. The objective of this study was to use this model to characterise the histological and molecular changes in bone remodelling, and relate these to the clinical disease development. METHODS: A histological and gene expression profiling time-course study on bone remodelling in CIA was linked to onset of clinical symptoms. Global gene expression was studied with a gene chip array system. RESULTS: The main histopathological changes in bone structure and inflammation occurred during the first two weeks following the onset of clinical symptoms in the joint. Hereafter, the inflammation declined and remodelling of formed bone dominated. Global gene expression profiling showed simultaneous upregulation of genes related to bone changes and inflammation in week 0 to 2 after onset of clinical disease. Furthermore, we observed time-dependent expression of genes involved in early and late osteoblast differentiation and function, which mirrored the histopathological bone changes. The differentially expressed genes belong to the bone morphogenetic pathway (BMP) and, in addition, include the osteoblast markers integrin-binding sialoprotein (Ibsp), bone gamma-carboxyglutamate protein (Bglap1), and secreted phosphoprotein 1 (Spp1). Pregnancy-associated protein A (Pappa) and periostin (Postn), differentially expressed in the early disease phase, are proposed to participate in bone formation, and we suggest that they play a role in early bone formation in the CIA model. Comparison to human genome-wide association studies (GWAS) revealed differential expression of several genes associated with human arthritis. CONCLUSIONS: In the CIA model, bone formation in the joint starts shortly after onset of clinical symptoms, which results in bony fusion within one to two weeks. This makes it a candidate model for investigating the relationship between inflammation and bone formation in inflammatory arthritis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13075-015-0531-7) contains supplementary material, which is available to authorized users. BioMed Central 2015-03-05 2015 /pmc/articles/PMC4391727/ /pubmed/25889670 http://dx.doi.org/10.1186/s13075-015-0531-7 Text en © Denninger et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Denninger, Katja CM
Litman, Thomas
Marstrand, Troels
Moller, Kristian
Svensson, Lars
Labuda, Tord
Andersson, Åsa
Kinetics of gene expression and bone remodelling in the clinical phase of collagen-induced arthritis
title Kinetics of gene expression and bone remodelling in the clinical phase of collagen-induced arthritis
title_full Kinetics of gene expression and bone remodelling in the clinical phase of collagen-induced arthritis
title_fullStr Kinetics of gene expression and bone remodelling in the clinical phase of collagen-induced arthritis
title_full_unstemmed Kinetics of gene expression and bone remodelling in the clinical phase of collagen-induced arthritis
title_short Kinetics of gene expression and bone remodelling in the clinical phase of collagen-induced arthritis
title_sort kinetics of gene expression and bone remodelling in the clinical phase of collagen-induced arthritis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4391727/
https://www.ncbi.nlm.nih.gov/pubmed/25889670
http://dx.doi.org/10.1186/s13075-015-0531-7
work_keys_str_mv AT denningerkatjacm kineticsofgeneexpressionandboneremodellingintheclinicalphaseofcollageninducedarthritis
AT litmanthomas kineticsofgeneexpressionandboneremodellingintheclinicalphaseofcollageninducedarthritis
AT marstrandtroels kineticsofgeneexpressionandboneremodellingintheclinicalphaseofcollageninducedarthritis
AT mollerkristian kineticsofgeneexpressionandboneremodellingintheclinicalphaseofcollageninducedarthritis
AT svenssonlars kineticsofgeneexpressionandboneremodellingintheclinicalphaseofcollageninducedarthritis
AT labudatord kineticsofgeneexpressionandboneremodellingintheclinicalphaseofcollageninducedarthritis
AT anderssonasa kineticsofgeneexpressionandboneremodellingintheclinicalphaseofcollageninducedarthritis